News

SK bioscience Co., the biopharmaceutical arm of South Korea's SK Group, said Wednesday it has achieved a "final victory" in a ...
Moderna’s use patent had been the only registered intellectual property in Korea pertaining to mRNA manufacturing. In 2023, SK Bioscience initiated legal proceedings to invalidate the patent ...
SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a ...